These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8906605)

  • 1. Cyclical changes in the renin-angiotensin-aldosterone system during the menstrual cycle of the baboon (Papio hamadryas).
    Harewood WJ; Gillin A; Mohamed S; Willis N; Lazzaro V; Duggin GG; Tiller DJ
    J Med Primatol; 1996 Aug; 25(4):267-71. PubMed ID: 8906605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetotoxicity of angiotensin-converting enzyme inhibition in primate pregnancy: a prospective, placebo-controlled study in baboons (Papio hamadryas).
    Harewood WJ; Phippard AF; Duggin GG; Horvath JS; Tiller DJ
    Am J Obstet Gynecol; 1994 Sep; 171(3):633-42. PubMed ID: 8092208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levels of renin, angiotensin I and II, angiotensin-converting enzyme and aldosterone in infancy and childhood.
    Fiselier TJ; Lijnen P; Monnens L; van Munster P; Jansen M; Peer P
    Eur J Pediatr; 1983 Oct; 141(1):3-7. PubMed ID: 6315441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
    Jensen J; Henik RA; Brownfield M; Armstrong J
    Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive effects of losartan and enalapril on blood pressure and plasma active renin.
    Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J
    Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives.
    Azizi M; Chatellier G; Guyene TT; Murieta-Geoffroy D; Ménard J
    Circulation; 1995 Aug; 92(4):825-34. PubMed ID: 7641363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lead exposure and changes in the renin-angiotensin-aldosterone system in man.
    Campbell BC; Meredith PA; Scott JJ
    Toxicol Lett; 1985 Apr; 25(1):25-32. PubMed ID: 2986320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension.
    van den Meiracker AH; Admiraal PJ; Derkx FH; Kleinbloesem C; Man in 't Veld AJ; van Brummelen P; Mulder P; Schalekamp MA
    J Hypertens; 1993 Aug; 11(8):831-8. PubMed ID: 8228207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An experimental study on the effects of the chronic administration of an angiotensin converting enzyme inhibitor (captopril) on blood pressure and the renin-angiotensin-aldosterone system (author's transl)].
    Goto A
    Nihon Naibunpi Gakkai Zasshi; 1980 Jun; 56(6):868-83. PubMed ID: 6997093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The changes in renin-angiotensin-aldosterone system in acute myocardial infarction and the effects of converting enzyme inhibitor-captopril].
    Jiang M
    Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Dec; 19(6):342-4, 396. PubMed ID: 1668233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interruption of prolonged ramipril treatment in hypertensive patients: effects on the renin-angiotensin system.
    Stephan D; Grima M; Welsch M; Barthelmebs M; Vasmant D; Imbs J
    Fundam Clin Pharmacol; 1996; 10(5):474-83. PubMed ID: 8902551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II/Angiotensin (1-7) ratio and 24-h blood pressure throughout the menstrual cycle and in women using oral contraceptives.
    Davis GC; Gibson KJ; Casley D; Brown MA
    J Hypertens; 2017 Jun; 35(6):1178-1186. PubMed ID: 28234675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B; Herlitz H; Aurell M; Hansson L
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum angiotensin-converting enzyme 2 concentration and angiotensin-(1-7) concentration in patients with acute heart failure patients requiring emergency hospitalization.
    Hisatake S; Kiuchi S; Kabuki T; Oka T; Dobashi S; Ikeda T
    Heart Vessels; 2017 Mar; 32(3):303-308. PubMed ID: 27421979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
    Schmitt F; Natov S; Martinez F; Lacour B; Hannedouche TP
    Clin Sci (Lond); 1996 Mar; 90(3):205-13. PubMed ID: 8777826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril versus enalapril: a comparison of 24 h humoral and hypotensive effects.
    Cottone S; Grasso L; D'Ignoto G; Contorno A; Ziletti T; Carapelle E; Carone MB; Fulantelli MA; Cerasola G
    Boll Soc Ital Biol Sper; 1987 Sep; 63(9):803-10. PubMed ID: 2833914
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects.
    Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH
    Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high doses of enalapril and benazepril on the pharmacologically activated renin-angiotensin-aldosterone system in clinically normal dogs.
    Ames MK; Atkins CE; Lee S; Lantis AC; zumBrunnen JR
    Am J Vet Res; 2015 Dec; 76(12):1041-50. PubMed ID: 26618728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.